A 0 1 0 1 O
diagnosis 2 11 2 11 O
of 12 14 12 14 O
CMML 15 19 15 19 B-cancer
, 19 20 19 20 O
unless 21 27 21 27 O
in 28 30 28 30 O
morphologic 31 42 31 42 O
CR 43 45 43 45 O

A 0 1 46 47 O
hematological 2 15 48 61 O
or 16 18 62 64 O
oncological 19 30 65 76 O
disease 31 38 77 84 O
( 39 40 85 86 O
not 40 43 86 89 O
listed 44 50 90 96 O
) 50 51 96 97 O
in 52 54 98 100 O
which 55 60 101 106 O
allogeneic 61 71 107 117 B-treatment
HSCT 72 76 118 122 I-treatment
is 77 79 123 125 O
thought 80 87 126 133 O
to 88 90 134 136 O
be 91 93 137 139 O
beneficial 94 104 140 150 O
, 104 105 150 151 O
and 106 109 152 155 O
the 110 113 156 159 O
disease 114 121 160 167 O
is 122 124 168 170 O
chemoresponsive 125 140 171 186 O

A 0 1 187 188 O
history 2 9 189 196 O
of 10 12 197 199 O
AML 13 16 200 203 B-cancer
with 17 21 204 208 O
< 22 23 209 210 O
20 24 26 211 213 B-upper_bound
% 26 27 213 214 I-upper_bound
residual 28 36 215 223 B-clinical_variable
blasts 37 43 224 230 I-clinical_variable
after 44 49 231 236 B-treatment
induction 50 59 237 246 I-treatment
therapy 60 67 247 254 I-treatment
and 68 71 255 258 O
persisting 72 82 259 269 O
with 83 87 270 274 O
< 88 89 275 276 O
20 89 91 276 278 O
% 91 92 278 279 O
blasts 93 99 280 286 O
for 100 103 287 290 O
at 104 106 291 293 O
least 107 112 294 299 O
8 113 114 300 301 B-lower_bound
weeks 115 120 302 307 I-lower_bound
without 121 128 308 315 O
reinduction 129 140 316 327 O

Active 0 6 328 334 O
involvement 7 18 335 346 O
of 19 21 347 349 O
the 22 25 350 353 O
central 26 33 354 361 O
nervous 34 41 362 369 O
system 42 48 370 376 O
with 49 53 377 381 O
malignancy 54 64 382 392 B-cancer

Acute 0 5 393 398 B-cancer
myeloid 6 13 399 406 I-cancer
leukemia 14 22 407 415 I-cancer
in 23 25 416 418 O
morphologic 26 37 419 430 O
CR 38 40 431 433 O
not 41 44 434 437 O
requiring 45 54 438 447 O
treatment 55 64 448 457 B-treatment
for 65 68 458 461 O
their 69 74 462 467 O
disease 75 82 468 475 O
for 83 86 476 479 O
6 87 88 480 481 B-upper_bound
weeks 89 94 482 487 I-upper_bound

Adequate 0 8 488 496 O
liver 9 14 497 502 O
function 15 23 503 511 O
as 24 26 512 514 O
defined 27 34 515 522 O
by 35 37 523 525 O
a 38 39 526 527 O
serum 40 45 528 533 B-clinical_variable
bilirubin 46 55 534 543 I-clinical_variable
< 56 57 544 545 O
1.8 57 60 545 548 B-upper_bound
, 60 61 548 549 O
AST 62 65 550 553 B-clinical_variable
or 66 68 554 556 I-clinical_variable
ALT 69 72 557 560 I-clinical_variable
< 73 74 561 562 O
2.5X 75 79 563 567 B-upper_bound
upper 80 85 568 573 I-upper_bound
limit 86 91 574 579 I-upper_bound
of 92 94 580 582 I-upper_bound
normal 95 101 583 589 I-upper_bound

Aplastic 0 8 590 598 B-chronic_disease
Anemia 9 15 599 605 I-chronic_disease

CMML 0 4 606 610 B-cancer
or 5 7 611 613 O
RAEB-2 8 14 614 620 B-cancer
must 15 19 621 625 O
demonstrate 20 31 626 637 O
chemo 32 37 638 643 B-treatment
- 37 38 643 644 I-treatment
responsiveness 38 52 644 658 I-treatment
. 52 53 658 659 O
Chemo 54 59 660 665 B-treatment
- 59 60 665 666 I-treatment
responsiveness 60 74 666 680 I-treatment
is 75 77 681 683 O
defined 78 85 684 691 O
as 86 88 692 694 O
a 89 90 695 696 O
blast 91 96 697 702 O
percentage 97 107 703 713 O
decrease 108 116 714 722 O
by 117 119 723 725 O
at 120 122 726 728 O
least 123 128 729 734 O
5 129 130 735 736 B-lower_bound
percentage 131 141 737 747 I-lower_bound
points 142 148 748 754 O
and 149 152 755 758 O
there 153 158 759 764 O
must 159 163 765 769 O
be 164 166 770 772 O
less 167 171 773 777 O
than 172 176 778 782 O
20 177 179 783 785 B-upper_bound
% 179 180 785 786 I-upper_bound
blasts 181 187 787 793 I-upper_bound
after 188 193 794 799 O
treatment 194 203 800 809 B-treatment
and 204 207 810 813 O
at 208 210 814 816 O
the 211 214 817 820 O
time 215 219 821 825 O
of 220 222 826 828 O
transplant 223 233 829 839 B-treatment

Creatinine 0 10 840 850 B-clinical_variable
Clearance 11 20 851 860 I-clinical_variable
of 21 23 861 863 O
≥ 24 25 864 865 O
60 26 28 866 868 B-lower_bound
mL 29 31 869 871 I-lower_bound
/ 31 32 871 872 I-lower_bound
min 32 35 872 875 I-lower_bound

DLCO 0 4 876 880 B-clinical_variable
( 5 6 881 882 I-clinical_variable
Diffusing 6 15 882 891 I-clinical_variable
Capacity 16 24 892 900 I-clinical_variable
of 25 27 901 903 I-clinical_variable
the 28 31 904 907 I-clinical_variable
Lung 32 36 908 912 I-clinical_variable
for 37 40 913 916 I-clinical_variable
Carbon 41 47 917 923 I-clinical_variable
Monoxide 48 56 924 932 I-clinical_variable
) 57 58 933 934 I-clinical_variable
≥45 59 62 935 938 O
% 62 63 938 939 I-lower_bound
of 64 66 940 942 O
predicted 67 76 943 952 O
corrected 77 86 953 962 O
for 87 90 963 966 O
hemoglobin 91 101 967 977 O
, 101 102 977 978 O
FEV-1 103 108 979 984 B-clinical_variable
( 109 110 985 986 I-clinical_variable
forced 110 116 986 992 I-clinical_variable
expiratory 117 127 993 1003 I-clinical_variable
volume 128 134 1004 1010 I-clinical_variable
at 135 137 1011 1013 I-clinical_variable
1 138 139 1014 1015 I-clinical_variable
second 140 146 1016 1022 I-clinical_variable
≥50 147 150 1023 1026 O
% 150 151 1026 1027 I-lower_bound
of 152 154 1028 1030 O
predicted 155 164 1031 1040 O

HCT 0 3 1041 1044 B-clinical_variable
- 3 4 1044 1045 I-clinical_variable
CI 4 6 1045 1047 I-clinical_variable
/ 6 7 1047 1048 O
Age 7 10 1048 1051 B-clinical_variable
Score 11 16 1052 1057 I-clinical_variable
≤ 17 18 1058 1059 O
5 19 20 1060 1061 O
points 21 27 1062 1068 O
( 28 29 1069 1070 O
Patients 29 37 1070 1078 O
with 38 42 1079 1083 O
greater 43 50 1084 1091 O
than 51 55 1092 1096 O
5 56 57 1097 1098 O
points 58 64 1099 1105 O
will 65 69 1106 1110 O
be 70 72 1111 1113 O
allowed 73 80 1114 1121 O
for 81 84 1122 1125 O
trial 85 90 1126 1131 O
with 91 95 1132 1136 O
approval 96 104 1137 1145 O
of 105 107 1146 1148 O
the 108 111 1149 1152 O
PI 112 114 1153 1155 O
and 115 118 1156 1159 O
the 119 122 1160 1163 O
Co 123 125 1164 1166 O
- 125 126 1166 1167 O
PI 126 128 1167 1169 O
or 129 131 1170 1172 O
his 132 135 1173 1176 O
designee 136 144 1177 1185 O
. 144 145 1185 1186 O
This 146 150 1187 1191 O
is 151 153 1192 1194 O
an 154 156 1195 1197 O
adjustment 157 167 1198 1208 O
to 168 170 1209 1211 O
account 171 178 1212 1219 O
for 179 182 1220 1223 O
healthy 183 190 1224 1231 O
patients 191 199 1232 1240 O
who 200 203 1241 1244 O
meet 204 208 1245 1249 O
the 209 212 1250 1253 O
spirit 213 219 1254 1260 O
of 220 222 1261 1263 O
this 223 227 1264 1268 O
protocol 228 236 1269 1277 O
but 237 240 1278 1281 O
have 241 245 1282 1286 O
histories 246 255 1287 1296 O
that 256 260 1297 1301 O
result 261 267 1302 1308 O
in 268 270 1309 1311 O
higher 271 277 1312 1318 O
than 278 282 1319 1323 O
HCT 283 286 1324 1327 O
- 286 287 1327 1328 O
CI 287 289 1328 1330 O
5 290 291 1331 1332 O
points 292 298 1333 1339 O
. 298 299 1339 1340 O
An 300 302 1341 1343 O
example 303 310 1344 1351 O
is 311 313 1352 1354 O
a 314 315 1355 1356 O
patient 316 323 1357 1364 O
with 324 328 1365 1369 O
a 329 330 1370 1371 O
solid 331 336 1372 1377 B-cancer
tumor 337 342 1378 1383 I-cancer
malignancy 343 353 1384 1394 I-cancer
in 354 356 1395 1397 O
their 357 362 1398 1403 O
remote 363 369 1404 1410 O
history 370 377 1411 1418 O
( 378 379 1419 1420 O
adds 379 383 1420 1424 O
3 384 385 1425 1426 O
points 386 392 1427 1433 O
to 393 395 1434 1436 O
HCT 396 399 1437 1440 O
- 399 400 1440 1441 O
CI 400 402 1441 1443 O
total 403 408 1444 1449 O
) 408 409 1449 1450 O
where 410 415 1451 1456 O
the 416 419 1457 1460 O
treatment 420 429 1461 1470 B-treatment
for 430 433 1471 1474 O
the 434 437 1475 1478 O
malignancy 438 448 1479 1489 O
occurred 449 457 1490 1498 O
years 458 463 1499 1504 O
to 464 466 1505 1507 O
decades 467 474 1508 1515 O
before 475 481 1516 1522 O
and 482 485 1523 1526 O
there 486 491 1527 1532 O
has 492 495 1533 1536 O
been 496 500 1537 1541 O
complete 501 509 1542 1550 O
recovery 510 518 1551 1559 O
of 519 521 1560 1562 O
toxicities 522 532 1563 1573 O

HCT 0 3 1574 1577 B-clinical_variable
- 3 4 1577 1578 I-clinical_variable
CI 4 6 1578 1580 I-clinical_variable
/ 6 7 1580 1581 O
age 7 10 1581 1584 B-age
Score 11 16 1585 1590 O
> 17 18 1591 1592 O
5 18 19 1592 1593 B-lower_bound
points 20 26 1594 1600 O
( 27 28 1601 1602 O
Patients 28 36 1602 1610 O
with 37 41 1611 1615 O
greater 42 49 1616 1623 O
than 50 54 1624 1628 O
5 55 56 1629 1630 O
points 57 63 1631 1637 O
will 64 68 1638 1642 O
be 69 71 1643 1645 O
allowed 72 79 1646 1653 O
for 80 83 1654 1657 O
trial 84 89 1658 1663 O
with 90 94 1664 1668 O
approval 95 103 1669 1677 O
of 104 106 1678 1680 O
the 107 110 1681 1684 O
Principal 111 120 1685 1694 O
Investigator 121 133 1695 1707 O
and 134 137 1708 1711 O
the 138 141 1712 1715 O
Co 142 144 1716 1718 O
- 144 145 1718 1719 O
Principal 145 154 1719 1728 O
Investigator 155 167 1729 1741 O
or 168 170 1742 1744 O
his 171 174 1745 1748 O
designee 175 183 1749 1757 O
. 183 184 1757 1758 O
This 185 189 1759 1763 O
is 190 192 1764 1766 O
an 193 195 1767 1769 O
adjustment 196 206 1770 1780 O
to 207 209 1781 1783 O
account 210 217 1784 1791 O
for 218 221 1792 1795 O
healthy 222 229 1796 1803 O
patients 230 238 1804 1812 O
who 239 242 1813 1816 O
meet 243 247 1817 1821 O
the 248 251 1822 1825 O
spirit 252 258 1826 1832 O
of 259 261 1833 1835 O
this 262 266 1836 1840 O
protocol 267 275 1841 1849 O
but 276 279 1850 1853 O
have 280 284 1854 1858 O
histories 285 294 1859 1868 O
that 295 299 1869 1873 O
result 300 306 1874 1880 O
in 307 309 1881 1883 O
higher 310 316 1884 1890 O
than 317 321 1891 1895 O
HCT 322 325 1896 1899 O
- 325 326 1899 1900 O
CI 326 328 1900 1902 O
5 329 330 1903 1904 O
points 331 337 1905 1911 O
. 337 338 1911 1912 O
An 339 341 1913 1915 O
example 342 349 1916 1923 O
is 350 352 1924 1926 O
a 353 354 1927 1928 O
patient 355 362 1929 1936 O
with 363 367 1937 1941 O
a 368 369 1942 1943 O
solid 370 375 1944 1949 B-cancer
tumor 376 381 1950 1955 I-cancer
malignancy 382 392 1956 1966 I-cancer
in 393 395 1967 1969 O
their 396 401 1970 1975 O
remote 402 408 1976 1982 O
history 409 416 1983 1990 O
( 417 418 1991 1992 O
adds 418 422 1992 1996 O
3 423 424 1997 1998 O
points 425 431 1999 2005 O
to 432 434 2006 2008 O
HCT 435 438 2009 2012 O
- 438 439 2012 2013 O
CI 439 441 2013 2015 O
total 442 447 2016 2021 O
) 447 448 2021 2022 O
where 449 454 2023 2028 O
the 455 458 2029 2032 O
treatment 459 468 2033 2042 B-treatment
for 469 472 2043 2046 O
the 473 476 2047 2050 O
malignancy 477 487 2051 2061 O
occurred 488 496 2062 2070 O
years 497 502 2071 2076 O
to 503 505 2077 2079 O
decades 506 513 2080 2087 O
before 514 520 2088 2094 O
and 521 524 2095 2098 O
there 525 530 2099 2104 O
has 531 534 2105 2108 O
been 535 539 2109 2113 O
complete 540 548 2114 2122 O
recovery 549 557 2123 2131 O
of 558 560 2132 2134 O
toxicities 561 571 2135 2145 O

HIV 0 3 2146 2149 B-chronic_disease
positive 4 12 2150 2158 O

Hodgkin 0 7 2159 2166 B-cancer
or 8 10 2167 2169 O
Indolent 11 19 2170 2178 B-cancer
Non 20 23 2179 2182 I-cancer
- 23 24 2182 2183 I-cancer
Hodgkin 24 31 2183 2190 I-cancer
's 31 33 2190 2192 I-cancer
lymphoma 34 42 2193 2201 I-cancer

KPS≥ 0 4 2202 2206 B-clinical_variable
90 5 7 2207 2209 B-lower_bound
% 7 8 2209 2210 I-lower_bound
patients 9 17 2211 2219 O
older 18 23 2220 2225 O
than 24 28 2226 2230 O
70 29 31 2231 2233 O
years 32 37 2234 2239 O
, 37 38 2239 2240 O
KPS≥ 39 43 2241 2245 O
80 44 46 2246 2248 B-lower_bound
% 46 47 2248 2249 I-lower_bound
patients 48 56 2250 2258 O
younger 57 64 2259 2266 O
than 65 69 2267 2271 O
70 70 72 2272 2274 O
years 73 78 2275 2280 O

LVEF 0 4 2281 2285 B-clinical_variable
( 5 6 2286 2287 I-clinical_variable
Left 6 10 2287 2291 I-clinical_variable
ventricular 11 22 2292 2303 I-clinical_variable
end 23 26 2304 2307 I-clinical_variable
diastolic 27 36 2308 2317 I-clinical_variable
function 37 45 2318 2326 I-clinical_variable
) 45 46 2326 2327 I-clinical_variable
of 47 49 2328 2330 O
> 50 51 2331 2332 O
/=45 51 55 2332 2336 O
% 55 56 2336 2337 I-lower_bound

Myeloma 0 7 2338 2345 B-cancer
with 8 12 2346 2350 O
< 13 14 2351 2352 O
5 15 16 2353 2354 B-upper_bound
% 16 17 2354 2355 I-upper_bound
plasma 18 24 2356 2362 O
cells 25 30 2363 2368 O
in 31 33 2369 2371 O
the 34 37 2372 2375 O
marrow 38 44 2376 2382 O

Myeloproliferative 0 18 2383 2401 B-cancer
disorders 19 28 2402 2411 I-cancer

Patients 0 8 2412 2420 O
must 9 13 2421 2425 O
be 14 16 2426 2428 O
willing 17 24 2429 2436 B-contraception_consent
to 25 27 2437 2439 I-contraception_consent
use 28 31 2440 2443 I-contraception_consent
contraception 32 45 2444 2457 I-contraception_consent
if 46 48 2458 2460 O
they 49 53 2461 2465 O
have 54 58 2466 2470 O
childbearing 59 71 2471 2483 O
potential 72 81 2484 2493 O

Patients 0 8 2494 2502 O
must 9 13 2503 2507 O
have 14 18 2508 2512 O
a 19 20 2513 2514 O
related 21 28 2515 2522 O
donor 29 34 2523 2528 O
who 35 38 2529 2532 O
is 39 41 2533 2535 O
HLA 42 45 2536 2539 O
mismatched 46 56 2540 2550 O
at 57 59 2551 2553 O
2 60 61 2554 2555 O
, 61 62 2555 2556 O
3 63 64 2557 2558 O
, 64 65 2558 2559 O
or 66 68 2560 2562 O
4 69 70 2563 2564 O
antigens 71 79 2565 2573 O
at 80 82 2574 2576 O
the 83 86 2577 2580 O
HLA 87 90 2581 2584 O
- 90 91 2584 2585 O
A 91 92 2585 2586 O
; 92 93 2586 2587 O
B 94 95 2588 2589 O
; 95 96 2589 2590 O
C 97 98 2591 2592 O
; 98 99 2592 2593 O
DR 100 102 2594 2596 O
loci 103 107 2597 2601 O
in 108 110 2602 2604 O
the 111 114 2605 2608 O
GVHD 115 119 2609 2613 B-chronic_disease
direction 120 129 2614 2623 O
. 129 130 2623 2624 O
( 131 132 2625 2626 O
Patients 132 140 2626 2634 O
with 141 145 2635 2639 O
related 146 153 2640 2647 O
donors 154 160 2648 2654 O
who 161 164 2655 2658 O
are 165 168 2659 2662 O
HLA 169 172 2663 2666 O
identical 173 182 2667 2676 O
or 183 185 2677 2679 O
are 186 189 2680 2683 O
a 190 191 2684 2685 O
1 192 193 2686 2687 O
- 193 194 2687 2688 O
antigen 194 201 2688 2695 O
mismatch 202 210 2696 2704 O
may 211 214 2705 2708 O
be 215 217 2709 2711 O
treated 218 225 2712 2719 O
on 226 228 2720 2722 O
this 229 233 2723 2727 O
therapeutic 234 245 2728 2739 O
approach 246 254 2740 2748 O
, 254 255 2748 2749 O
but 256 259 2750 2753 O
will 260 264 2754 2758 O
have 265 269 2759 2763 O
their 270 275 2764 2769 O
outcomes 276 284 2770 2778 O
will 285 289 2779 2783 O
not 290 293 2784 2787 O
be 294 296 2788 2790 O
part 297 301 2791 2795 O
of 302 304 2796 2798 O
the 305 308 2799 2802 O
statistical 309 320 2803 2814 O
aims 321 325 2815 2819 O
of 326 328 2820 2822 O
the 329 332 2823 2826 O
study 333 338 2827 2832 O
( 339 340 2833 2834 O
see 340 343 2834 2837 O
Statistical 344 355 2838 2849 O
Section 356 363 2850 2857 O
) 363 364 2857 2858 O
. 364 365 2858 2859 O
The 366 369 2860 2863 O
HLA 370 373 2864 2867 O
matched 374 381 2868 2875 O
related 382 389 2876 2883 O
category 390 398 2884 2892 O
includes 399 407 2893 2901 O
patients 408 416 2902 2910 O
with 417 421 2911 2915 O
a 422 423 2916 2917 O
syngeneic 424 433 2918 2927 O
donor 434 439 2928 2933 O

Patients 0 8 2934 2942 O
must 9 13 2943 2947 O
have 14 18 2948 2952 O
had 19 22 2953 2956 O
front 23 28 2957 2962 O
line 29 33 2963 2967 O
therapy 34 41 2968 2975 B-treatment
for 42 45 2976 2979 O
their 46 51 2980 2985 O
disease 52 59 2986 2993 O

Patients 0 8 2994 3002 O
who 9 12 3003 3006 O
have 13 17 3007 3011 O
received 18 26 3012 3020 O
alemtuzumab 27 38 3021 3032 B-treatment
or 39 41 3033 3035 O
antithymocyte 42 55 3036 3049 B-treatment
globulin 56 64 3050 3058 I-treatment
within 65 71 3059 3065 O
8 72 73 3066 3067 B-upper_bound
weeks 74 79 3068 3073 I-upper_bound
of 80 82 3074 3076 O
the 83 86 3077 3080 O
transplant 87 97 3081 3091 B-treatment
admission 98 107 3092 3101 O
. 107 108 3101 3102 O
The 109 112 3103 3106 O
absence 113 120 3107 3114 O
of 121 123 3115 3117 O
these 124 129 3118 3123 O
therapies 130 139 3124 3133 B-treatment
in 140 142 3134 3136 O
the 143 146 3137 3140 O
medical 147 154 3141 3148 O
record 155 161 3149 3155 O
will 162 166 3156 3160 O
serve 167 172 3161 3166 O
as 173 175 3167 3169 O
documentation 176 189 3170 3183 O
that 190 194 3184 3188 O
they 195 199 3189 3193 O
were 200 204 3194 3198 O
not 205 208 3199 3202 O
given 209 214 3203 3208 O

Patients 0 8 3209 3217 O
with 9 13 3218 3222 O
evidence 14 22 3223 3231 O
of 23 25 3232 3234 O
another 26 33 3235 3242 O
malignancy 34 44 3243 3253 B-cancer
, 44 45 3253 3254 O
exclusive 46 55 3255 3264 O
of 56 58 3265 3267 O
a 59 60 3268 3269 O
skin 61 65 3270 3274 B-cancer
cancer 66 72 3275 3281 I-cancer
that 73 77 3282 3286 O
requires 78 86 3287 3295 O
only 87 91 3296 3300 O
local 92 97 3301 3306 O
treatment 98 107 3307 3316 B-treatment
, 107 108 3316 3317 O
should 109 115 3318 3324 O
not 116 119 3325 3328 O
be 120 122 3329 3331 O
enrolled 123 131 3332 3340 O
on 132 134 3341 3343 O
this 135 139 3344 3348 O
protocol 140 148 3349 3357 O

Patients 0 8 3358 3366 O
with 9 13 3367 3371 O
life 14 18 3372 3376 B-clinical_variable
expectancy 19 29 3377 3387 I-clinical_variable
of 30 32 3388 3390 O
< 33 34 3391 3392 O
6 35 36 3393 3394 B-upper_bound
months 37 43 3395 3401 I-upper_bound
for 44 47 3402 3405 O
reasons 48 55 3406 3413 O
other 56 61 3414 3419 O
than 62 66 3420 3424 O
their 67 72 3425 3430 O
underlying 73 83 3431 3441 O
hematologic 84 95 3442 3453 B-chronic_disease
/ 95 96 3453 3454 O
oncologic 96 105 3454 3463 B-chronic_disease
disorder 106 114 3464 3472 I-chronic_disease

Performance 0 11 3473 3484 B-clinical_variable
status 12 18 3485 3491 I-clinical_variable
< 19 20 3492 3493 O
90 21 23 3494 3496 B-upper_bound
% 23 24 3496 3497 I-upper_bound
in 25 27 3498 3500 O
patients 28 36 3501 3509 O
70 37 39 3510 3512 O
years 40 45 3513 3518 O
old 46 49 3519 3522 O
or 50 52 3523 3525 O
greater 53 60 3526 3533 O
, 60 61 3533 3534 O
< 62 63 3535 3536 O
80 63 65 3536 3538 B-upper_bound
% 65 66 3538 3539 I-upper_bound
in 67 69 3540 3542 O
patients 70 78 3543 3551 O
less 79 83 3552 3556 O
than 84 88 3557 3561 O
age 89 92 3562 3565 B-age
70 93 95 3566 3568 O
years 96 101 3569 3574 O

Pregnancy 0 9 3575 3584 B-pregnancy

RA 0 2 3585 3587 B-chronic_disease
or 3 5 3588 3590 O
RARS 6 10 3591 3595 B-chronic_disease
or 11 13 3596 3598 O
isolated 14 22 3599 3607 O
5q- 23 26 3608 3611 O
can 27 30 3612 3615 O
proceed 31 38 3616 3623 O
to 39 41 3624 3626 O
transplant 42 52 3627 3637 B-treatment
without 53 60 3638 3645 O
any 61 64 3646 3649 O
treatment 65 74 3650 3659 B-treatment

RAEB-1 0 6 3660 3666 B-chronic_disease
, 6 7 3666 3667 O
RCMD+/-RS 8 17 3668 3677 B-cancer
, 17 18 3677 3678 O
or 19 21 3679 3681 O
MDS 22 25 3682 3685 B-cancer
NOS 26 29 3686 3689 I-cancer
with 30 34 3690 3694 O
stable 35 41 3695 3701 O
disease 42 49 3702 3709 O
for 50 53 3710 3713 O
6 54 55 3714 3715 B-upper_bound
months 56 62 3716 3722 I-upper_bound
( 63 64 3723 3724 O
as 64 66 3724 3726 O
documented 67 77 3727 3737 O
by 78 80 3738 3740 O
serial 81 87 3741 3747 O
bone 88 92 3748 3752 O
marrow 93 99 3753 3759 O
examinations 100 112 3760 3772 O
) 112 113 3772 3773 O
in 114 116 3774 3776 O
the 117 120 3777 3780 O
absence 121 128 3781 3788 O
of 129 131 3789 3791 O
any 132 135 3792 3795 O
therapy 136 143 3796 3803 B-treatment
but 144 147 3804 3807 O
growth 148 154 3808 3814 B-treatment
factors 155 162 3815 3822 I-treatment
or 163 165 3823 3825 O
transfusion 166 177 3826 3837 B-treatment
support 178 185 3838 3845 I-treatment
. 185 186 3845 3846 O
Patients 187 195 3847 3855 O
who 196 199 3856 3859 O
require 200 207 3860 3867 O
treatment 208 217 3868 3877 B-treatment
to 218 220 3878 3880 O
control 221 228 3881 3888 O
their 229 234 3889 3894 O
disease 235 242 3895 3902 O
must 243 247 3903 3907 O
show 248 252 3908 3912 O
chemo 253 258 3913 3918 O
- 258 259 3918 3919 O
responsiveness 259 273 3919 3933 O

